A new study showcases that a repurposed cancer drug significantly reduces the frequency of severe nosebleeds in patients suffering from hereditary hemorrhagic telangiectasia, a condition caused by abnormal blood vessel formation.
The research indicates that this innovative treatment not only alleviates nosebleeds but may also address other related symptoms, enhancing the quality of life for those affected by this hereditary disease.
#hereditary-hemorrhagic-telangiectasia #cancer-drug-repurposing #medical-treatment #nosebleeds #symptom-relief
Collection
[
|
...
]